Clinical management of older persons with haemophilia

Critical Reviews in Oncology/Hematology

Volumn 89, Issue 2, 2014, Pages 197-206

  Hermans, C ^a   de Moerloose, P ^b   Dolan, G ^c  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^c QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

Ageing; Cancer; Cardiovascular disease; Comorbidity; Haemophilia

Indexed keywords

ADDICTION; ALCOHOL CONSUMPTION; CEREBROVASCULAR ACCIDENT; CLINICAL EXAMINATION; COLORECTAL CANCER; COMORBIDITY; DEMENTIA; DEPRESSION; END STAGE LIVER DISEASE; HEMOPHILIA; HEPATITIS B; HEPATITIS C; HUMAN; ISCHEMIC HEART DISEASE; LUNG CANCER; MALE SEXUAL DYSFUNCTION; OSTEOPOROSIS; PEOPLE WITH HEMOPHILIA; PHYSICAL ACTIVITY; PROSTATE CANCER; REVIEW; SCREENING TEST;

AGEING; CANCER; CARDIOVASCULAR DISEASE; COMORBIDITY; HAEMOPHILIA;

AGING; CARDIOVASCULAR DISEASES; COMORBIDITY; HEMOPHILIA A; HEMOPHILIA B; HUMANS; LIVER DISEASES; NEOPLASMS; OSTEOPOROSIS;

EID: 84892499243     PISSN: 10408428     EISSN: 18790461     Source Type: Journal    
DOI: 10.1016/j.critrevonc.2013.07.005     Document Type: Review

References (78)

1. Colvin B.T., Astermark J., Fischer K., Gringeri A., Lassila R., Schramm W., et al. European principles of haemophilia care. Haemophilia 2008, 14:361-374.
2. Darby S.C., Kan S.W., Spooner R.J., Giangrande P.L., Hill F.G., Hay C.R., et al. Mortality rates, life expectancy, and causes of death in people with hemophilia A or B in the United Kingdom who were not infected with HIV. Blood 2007, 110:815-825.
3. Street A., Hill K., Sussex B., Warner M., Scully M.F. Haemophilia and ageing. Haemophilia 2006, 12(Suppl. 3):8-12.
4. Mauser-Bunschoten E.P., Fransen Van De Putte D.E., Schutgens R.E. Co-morbidity in the ageing haemophilia patient: the down side of increased life expectancy. Haemophilia 2009, 15:853-863.
5. Soucie J.M., Nuss R., Evatt B., Abdelhak A., Cowan L., Hill H., et al. Mortality among males with hemophilia: relations with source of medical care. The hemophilia surveillance system project investigators. Blood 2000, 96:437-442.
6. de Moerloose P., Fischer K., Lambert T., Windyga J., Batorova A., Lavigne-Lissalde G., et al. Recommendations for assessment, monitoring and follow-up of patients with haemophilia. Haemophilia 2012, 18:19-25.
7. Allender S., Scarborough P., Peto V., Rayner M., Leal J., Luengo-Fernandez R., et al. European cardiovascular disease statistics: 2008 edition 2005, British Heart Foundation, London.
8. Conroy R.M., Pyörälä K., Fitzgerald A.P., Sans S., Menotti A., De Backer G., et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. European Heart Journal 2003, 24(11):987-1003.
9. Hippisley-Cox J., Coupland C., Vinogradova Y., Robson J., Minhas R., Sheikh A., et al. Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2. BMJ 2008, 336:1475-1482.
10. Perk J., De Backer G., Gohlke H., Graham I., Reiner Z., Verschuren M., et al. European guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). European Heart Journal 2012, 33:1635-1701.
11. Coresh J., Selvin E., Stevens L.A., Manzi J., Kusek J.W., Eggers P., et al. Prevalence of chronic kidney disease in the United States. The Journal of the American Medical Association 2007, 298:2038-2047.
12. Lambing A., Kuriakose P., Lanzon J., Kachalsky E. Dialysis in the haemophilia patient: a practical approach to care. Haemophilia 2009, 15:33-42.
13. Drey N., Roderick P., Mullee M., Rogerson M. A population-based study of the incidence and outcomes of diagnosed chronic kidney disease. American Journal of Kidney Diseases 2003, 42:677-684.
14. Rosendaal F.R., Briët E., Stibbe J., van Herpen G., Leuven J.A., Hofman A., et al. Haemophilia protects against ischaemic heart disease: a study of risk factors. British Journal of Haematology 1990, 75:525-530.
15. Plug I., Van Der Bom J.G., Peters M., Mauser-Bunschoten E.P., De Goede-Bolder A., Heijnen L., et al. Mortality and causes of death in patients with hemophilia, 1992-2001: a prospective cohort study. Journal of Thrombosis and Haemostasis 2006, 4:510-516.
16. Fransen van de Putte D.E., Fischer K., Pulles A.E., Roosendaal G., Biesma D.H., Schutgens R.E., et al. Non-fatal cardiovascular disease, malignancies, and other co-morbidity in adult haemophilia patients. Thrombosis Research 2012, 130:157-162.
17. Biere-Rafi S., Tuinenburg A., Haak B.W., Peters M., Huijgen R., De Groot E., et al. Factor VIII deficiency does not protect against atherosclerosis. Journal of Thrombosis and Haemostasis 2012, 10:30-37.
18. Tuinenburg A., Rutten A., Kavousi M., Leebeek F.W., Ypma P.F., Laros-van Gorkom B.A. Coronary artery calcification in hemophilia A: no evidence for a protective effect of factor VIII deficiency on atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology 2012, 32:799-804.
19. Fogarty P.F., Olin J.W., Kessler C.M., Konkle B.A., Aledort L.M. An algorithmic approach to peripheral artery disease in hemophilia: extrapolation of management principles from noncoagulopathic patients. Blood Coagulation and Fibrinolysis 2012, 23:23-29.
20. Kulkarni R., Soucie J.M., Evatt B.L. Hemophilia surveillance system project investigators. Prevalence and risk factors for heart disease among males with hemophilia. American Journal of Hematology 2005, 79:36-42.
21. Lim M.Y., Pruthi R.K. Cardiovascular disease risk factors: prevalence and management in adult hemophilia patients. Blood Coagulation and Fibrinolysis 2011, 22:402-406.
22. Biere-Rafi S., Baarslag M.A., Peters M., Kruip M.J., Kraaijenhagen R.A., Den Heijer M. Cardiovascular risk assessment in haemophilia patients. Thrombosis and Haemostasis 2011, 105:274-278.
23. Siboni S.M., Mannucci P.M., Gringeri A., Franchini M., Tagliaferri A., Ferretti M., et al. Health status and quality of life of elderly persons with severe hemophilia born before the advent of modern replacement therapy. Journal of Thrombosis and Haemostasis 2009, 7:780-786.
24. Fransen van de Putte D.E., Fischer K., Makris M., Tait R.C., Collins P.W., Meijer K. Increased prevalence of hypertension in haemophilia patients. Thrombosis and Haemostasis 2012, 108:750-755.
25. Fransen van de Putte D.E., Fischer K., Makris M., Tait R.C., Chowdary P., Collins P.W.M., et al. Unfavourable cardiovascular disease risk profiles in a cohort of Dutch and British haemophilia patients. Thrombosis and Haemostasis 2013, 109:16-23.
26. World Health Organization. Cancer. http://www.euro.who.int/en/what-we-do/health-topics/noncommunicable-diseases/cancer.
27. Ferlay J., Parkin D.M., Steliarova-Foucher E. Estimates of cancer incidence and mortality in Europe in 2008. European Journal of Cancer 2010, 46:765-781.
28. National Institute for Health and Clinical Excellence. Lung cancer: The diagnosis and treatment of lung cancer. Clinical Guideline CG21. NICE, April 2011.
29. Heidenreich A, Bastian PJ, Bellmunt J, Bolla M, Joniau S, Mason MS, et al. Guidelines on Prostate Cancer. European Association of Urology 2012. Available at http://www.uroweb.org/guidelines/online-guidelines/.
30. Horwich A., Parker C., Bangma C., Kataja V. ESMO Guidelines Working Group. Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology 2010, 21(Suppl. 5):v129-v133.
31. International Agency for Research on Cancer (IARC) European guidelines for quality assurance in colorectal cancer screening and diagnosis 2010, Publications Office of the European Union, Luxembourg. 1st Edition. N. Segnan, J. Patnick, L. von Karsa (Eds.).
32. Dunn A.L., Austin H., Soucie J.M. Prevalence of malignancies among U.S. male patients with haemophilia: a review of the haemophilia surveillance system. Haemophilia 2012, 18:532-539.
33. Goedert J.J., Eyster M.E., Lederman M.M., Mandalaki T., de Moerloose P., White G.C., et al. End-stage liver disease in persons with hemophilia and transfusion-associated infections. Blood 2002, 100:1584-1589.
34. Posthouwer D., Makris M., Yee T.T., Fischer K., van Veen J.J., Griffioen A., et al. Progression to end-stage liver disease in patients with inherited bleeding disorders and hepatitis C: an international, multicenter cohort study. Blood 2007, 109:3667-3671.
35. Zoulim F., Bailly F. New approaches to the management of hepatitis C in haemophilia in 2012. Haemophilia 2012, 18(Suppl. 4):28-33.
36. Boursier J., de Ledinghen V., Zarski J.P., Fouchard-Hubert I., Gallois Y., Oberti F., et al. Comparison of eight diagnostic algorithms for liver fibrosis in hepatitis C: new algorithms are more precise and entirely noninvasive. Hepatology 2012, 55:58-67.
37. Castera L., Bedossa P. How to assess liver fibrosis in chronic hepatitis C: serum markers or transient elastography vs. liver biopsy?. Liver International 2011, 31(Suppl. 1):13-17.
38. Kanis J. Diagnosis of osteoporosis and assessment of fracture risk. Lancet 2002, 359:1929-1936.
39. Scottish Intercollegiate Guidelines Network (SIGN). Management of Osteoporosis. Guideline No. 71. June 2003 (Updated April 2004). Available at http://www.sign.ac.uk/guidelines/fulltext/71/index.html.
40. International Osteoporosis Foundation. Available at http://www.iofbonehealth.org/facts-and-statistics.html.
41. Gallacher S.J., Deighan C., Wallace A.M., Cowan R.A., Fraser W.D., Fenner J.A., et al. Association of severe haemophilia A with osteoporosis: a densitometric and biochemical study. Quarterly Journal of Medicine 1994, 87:181-186.
42. Wallny T.A., Scholz D.T., Oldenburg J., Nicolay C., Ezziddin S., Pennekamp P.H., et al. Osteoporosis in haemophilia-an underestimated comorbidity?. Haemophilia 2007, 13:79-84.
43. Nair A.P., Jijina F., Ghosh K., Madkaikar M., Shrikhande M., Nema M. Osteoporosis in young haemophiliacs from western India. American Journal of Hematology 2007, 82:453-457.
44. Gerstner G., Damiano M.L., Tom A., Worman C., Schultz W., Recht M., et al. Prevalence and risk factors associated with decreased bone mineral density in patients with haemophilia. Haemophilia 2009, 15:559-565.
45. Abdelrazik N., Reda M., El-Ziny M., Rabea H. Evaluation of bone mineral density in children with hemophilia: Mansoura University children hospital (MUCH) experience, Mansoura, Egypt. Hematology 2007, 12:431-437.
46. Mansouritorghabeh H., Rezaieyazdi Z., Badiei Z. Are individuals with severe haemophilia A prone to reduced bone density. Rheumatology International 2008, 28:1079-1083.
47. Barnes C., Wong P., Egan B., Speller T., Cameron F., Jones G., et al. Reduced bone density among children with severe hemophilia. Pediatrics 2004, 114:e177-e181.
48. Christoforidis A., Economou M., Papadopoulou E., Kazantzidou E., Gompakis N., Athanassiou-Metaxa M. Bone status of children with hemophilia A assessed with quantitative ultrasound sonography (QUS) and dual energy X-ray absorptiometry (DXA). Journal of Pediatric Hematology/Oncology 2010, 32:e259-e263.
49. Khawaji M., Akesson K., Berntorp E. Long-term prophylaxis in severe haemophilia seems to preserve bone mineral density. Haemophilia 2009, 15:261-266.
50. Khawaji M., Astermark J., Akesson K., Berntorp E. Physical activity for prevention of osteoporosis in patients with severe haemophilia on long-term prophylaxis. Haemophilia 2010, 16:495-501.
51. Kovacs C.S. Hemophilia, low bone mass, and osteopenia/osteoporosis. Transfusion and Apheresis Scienc 2008, 38:33-40.
52. Warburton D.E., Nicol C.W., Bredin S.S. Health benefits of physical activity: the evidence. CMAJ 2006, 174:801-809.
53. World Health Organization. Global Recommendations on Physical Activity for Health. WHO, Geneva, 2011. Summary available at http://www.who.int/dietphysicalactivity/pa/en/index.html.
54. World Federation of Hemophilia (WFH). Guidelines for the management of hemophilia. Available at http://www.wfh.org/index.asp%3Flang=EN.
55. van Genderen F.R., van Meeteren N.L., van der Bom J.G., Heijnen L., de Kleijn P., van den Berg H.M., et al. Functional consequences of haemophilia in adults: the development of the Haemophilia Activities List. Haemophilia 2004, 10:565-571.
56. van Genderen F.R., Westers P., Heijnen L., de Kleijn P., van den Berg H.M., Helders P.J., et al. Measuring patients' perceptions on their functional abilities: validation of the haemophilia activities list. Haemophilia 2006, 12:36-46.
57. Humphries T.J., Kessler C.M. The challenge of pain evaluation in haemophilia: can pain evaluation and quantification be improved by using pain instruments from other clinical situations. Haemophilia 2013, 19:181-187.
58. World Health Organization. Global strategy to reduce harmful use of alcohol. WHO, Geneva, 2010. Available at http://www.who.int/substance_abuse/activities/gsrhua/en/index.html.
59. Ewing J.A. Detecting alcoholism. The CAGE questionnaire. JAMA 1984, 252:1905-1907.
60. Bush K., Kivlahan D.R., McDonell M.B., Fihn S.D., Bradley K.A. The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test. Archives of Internal Medicine 1998, 158:1789-1795.
61. Murray C.J., Lopez A.D. Alternative projections of mortality and disability by cause 1990-2020: global burden of disease study. Lancet 1997, 349:1498-1504.
62. National Institute for Health and Clinical Excellence. The treatment and management of depression in adults with chronic physical health problems. Clinical Guideline 23. NICE, October 2009.
63. Himelhoch S., Weller W., Wu A., Anderson G., Cooper L. Chronic medical illness, depression, and use of acute medical services among Medicare beneficiaries. Medical Care 2004, 42:512-521.
64. Iannone M., Pennick L., Tom A., Cui H., Gilbert M., Weihs K., et al. Prevalence of depression in adults with haemophilia. Haemophilia 2012, 10.1111/j. 1365-2516.2012.02863.x.
65. http://www.depression-primarycare.org/clinicians/toolkits/materials/forms/phq9/.
66. Zigmond A.S., Snaith R.P. The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica 1983, 67:361-370.
67. Beck A.T., Steer R.A., Ball R., Ranieri W. Comparison of beck depression inventories-IA and -II in psychiatric outpatients. Journal of Personality Assessment 1996, 67:588-597.
68. NHS Public Health Resource Unit. Appraisal for screening for Alzheimer's disease. September 2009. Available at http://www.screening.nhs.uk/alzheimers.
69. Folstein M.F., Folstein S.E., McHugh P.R. Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research 1975, 12:189-198.
70. Brodaty H., Low L.F., Gibson L., Burns K. What is the best dementia screening instrument for general practitioners to use?. American Journal of Geriatric Psychiatry 2006, 14:391-400.
71. Milne A., Culverwell A., Guss R., Tuppen J., Whelton R. Screening for dementia in primary care: a review of the use, efficacy and quality of measures. International Psychogeriatrics 2008, 20:911-926.
72. Borson S., Scanlan J., Brush M., Vitaliano P., Dokmak A. The mini-cog: a cognitive 'vital signs' measure for dementia screening in multi-lingual elderly. International Journal of Geriatric Psychiatry 2000, 15:1021-1027.
73. Feldman H.A., Goldstein I., Hatzichristou D.G., Krane R.J., McKinlay J.B. Impotence and its medical and psychosocial correlates: results of the Massachusetts male aging study. Journal of Urology 1994, 151:54-61.
74. Thompson I.M., Tangen C.M., Goodman P.J., Probstfield J.L., Moinpour C.M., Coltman C.A. Erectile dysfunction and subsequent cardiovascular disease. JAMA 2005, 294:2996-3002.
75. Rosen R.C., Jackson G., Kostis J.B. Erectile dysfunction and cardiac disease: recommendations of the second Princeton conference. Current Urology Reports 2006, 7:490-496.
76. Bar-Chama N., Snyder S., Aledort L. Sexual evaluation and treatment of ageing males with haemophilia. Haemophilia 2011, 17:875-883.
77. Rosen R.C., Cappelleri J.C., Smith M.D., Lipsky J., Peña B.M. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. International Journal of Impotence Research 1999, 11:319-326.
78. Mannucci P.M., Schutgens R.E., Santagostino E., How Mauser-Bunschoten E.P. I treat age-related morbidities in elderly persons with hemophilia. Blood 2009, 114:5256-5263.